Phio Pharmaceuticals Corp.
PHIO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $14,174 | $1,580 | $5,069 | $12,818 |
| - Cash | $5,382 | $8,490 | $11,781 | $24,057 |
| + Debt | $0 | $35 | $170 | $295 |
| Enterprise Value | $8,792 | -$6,875 | -$6,542 | -$10,944 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$3,643 | -$6,332 | -$7,012 | -$8,886 |
| % Margin | – | – | – | – |
| EBITDA | -$7,385 | -$10,642 | -$11,391 | -$13,436 |
| % Margin | – | – | – | – |
| Net Income | -$7,150 | -$10,826 | -$11,480 | -$13,287 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.91 | -46.76 | -89.61 | -111.32 |
| % Growth | 98.1% | 47.8% | 19.5% | – |
| Operating Cash Flow | -$7,112 | -$10,749 | -$12,129 | -$11,858 |
| Capital Expenditures | -$1 | -$5 | -$121 | -$51 |
| Free Cash Flow | -$7,113 | -$10,754 | -$12,250 | -$11,909 |